This is not the most recent version of the article. View current version (21 JUL 2014)

Intervention Review

Tiotropium versus placebo for chronic obstructive pulmonary disease

  1. Charlotta Karner1,*,
  2. Jimmy Chong2,
  3. Phillippa Poole3

Editorial Group: Cochrane Airways Group

Published Online: 11 JUL 2012

Assessed as up-to-date: 9 FEB 2012

DOI: 10.1002/14651858.CD009285.pub2


How to Cite

Karner C, Chong J, Poole P. Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2012, Issue 7. Art. No.: CD009285. DOI: 10.1002/14651858.CD009285.pub2.

Author Information

  1. 1

    BMJ Group, BMJ Evidence Centre, London, UK

  2. 2

    Tauranga Hospital, Tauranga, New Zealand

  3. 3

    University of Auckland, Department of Medicine, Auckland, New Zealand

*Charlotta Karner, BMJ Evidence Centre, BMJ Group, Tavistock Square, London, WC1H 9JR, UK. ckarner@bmjgroup.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 11 JUL 2012

SEARCH

This is not the most recent version of the article. View current version (21 JUL 2014)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peter K. Lindenauer, Meng-Shiou Shieh, Penelope S. Pekow, Mihaela S. Stefan, Use and Outcomes Associated with Long-acting Bronchodilators among Patients Hospitalized for Chronic Obstructive Pulmonary Disease, Annals of the American Thoracic Society, 2014, 11, 8, 1186

    CrossRef